These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 31768101)

  • 1. Knockdown of SET Domain, Bifurcated 1 suppresses head and neck cancer cell viability and wound-healing ability in vitro.
    Özdaş S
    Turk J Biol; 2019; 43(5):281-292. PubMed ID: 31768101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation.
    Wu M; Fan B; Guo Q; Li Y; Chen R; Lv N; Diao Y; Luo Y
    Biol Res; 2018 Oct; 51(1):39. PubMed ID: 30309377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DSG3 is overexpressed in head neck cancer and is a potential molecular target for inhibition of oncogenesis.
    Chen YJ; Chang JT; Lee L; Wang HM; Liao CT; Chiu CC; Chen PJ; Cheng AJ
    Oncogene; 2007 Jan; 26(3):467-76. PubMed ID: 16878157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of Aurora-A-FLJ10540 signaling axis prohibits the malignant state of head and neck cancer.
    Chen CH; Chang AY; Li SH; Tsai HT; Shiu LY; Su LJ; Wang WL; Chiu TJ; Luo SD; Huang TL; Chien CY
    Mol Cancer; 2015 Apr; 14():83. PubMed ID: 25889801
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic signature associated with radioresistance in head and neck cancer via transcriptomic and bioinformatic analyses.
    You GR; Cheng AJ; Lee LY; Huang YC; Liu H; Chen YJ; Chang JT
    BMC Cancer; 2019 Jan; 19(1):64. PubMed ID: 30642292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting acid ceramidase sensitises head and neck cancer to cisplatin.
    Roh JL; Park JY; Kim EH; Jang HJ
    Eur J Cancer; 2016 Jan; 52():163-72. PubMed ID: 26687835
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DNA promoter hypermethylation contributes to down-regulation of galactocerebrosidase gene in lung and head and neck cancers.
    Peng J; Chen B; Shen Z; Deng H; Liu D; Xie X; Gan X; Xu X; Huang Z; Chen J
    Int J Clin Exp Pathol; 2015; 8(9):11042-50. PubMed ID: 26617822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Up-regulation of histone methyltransferase SETDB1 by multiple mechanisms in hepatocellular carcinoma promotes cancer metastasis.
    Wong CM; Wei L; Law CT; Ho DW; Tsang FH; Au SL; Sze KM; Lee JM; Wong CC; Ng IO
    Hepatology; 2016 Feb; 63(2):474-87. PubMed ID: 26481868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BACH1 silencing by siRNA inhibits migration of HT-29 colon cancer cells through reduction of metastasis-related genes.
    Davudian S; Shajari N; Kazemi T; Mansoori B; Salehi S; Mohammadi A; Shanehbandi D; Shahgoli VK; Asadi M; Baradaran B
    Biomed Pharmacother; 2016 Dec; 84():191-198. PubMed ID: 27657827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epithelial-mesenchymal transition transcription factor ZEB1/ZEB2 co-expression predicts poor prognosis and maintains tumor-initiating properties in head and neck cancer.
    Chu PY; Hu FW; Yu CC; Tsai LL; Yu CH; Wu BC; Chen YW; Huang PI; Lo WL
    Oral Oncol; 2013 Jan; 49(1):34-41. PubMed ID: 22892238
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Induction of ferroptotic cell death for overcoming cisplatin resistance of head and neck cancer.
    Roh JL; Kim EH; Jang HJ; Park JY; Shin D
    Cancer Lett; 2016 Oct; 381(1):96-103. PubMed ID: 27477897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced expression of SETDB1 possesses prognostic value and promotes cell proliferation, migration and invasion in nasopharyngeal carcinoma.
    Huang J; Huang W; Liu M; Zhu J; Jiang D; Xiong Y; Zhen Y; Yang D; Chen Z; Peng L; Yu Z
    Oncol Rep; 2018 Aug; 40(2):1017-1025. PubMed ID: 29901162
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional analysis of ESM1 by siRNA knockdown in primary and metastatic head and neck cancer cells.
    Bender O; Gunduz M; Cigdem S; Hatipoglu OF; Acar M; Kaya M; Grenman R; Gunduz E; Ugur KS
    J Oral Pathol Med; 2018 Jan; 47(1):40-47. PubMed ID: 29024069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems.
    Shin D; Kim EH; Lee J; Roh JL
    Redox Biol; 2017 Oct; 13():219-227. PubMed ID: 28582730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aurora kinases are a novel therapeutic target for HPV-positive head and neck cancers.
    Shaikh MH; Idris A; Johnson NW; Fallaha S; Clarke DTW; Martin D; Morgan IM; Gabrielli B; McMillan NAJ
    Oral Oncol; 2018 Nov; 86():105-112. PubMed ID: 30409290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of neurofilament light polypeptide in head and neck cancer chemoresistance.
    Chen B; Chen J; House MG; Cullen KJ; Nephew KP; Guo Z
    Mol Cancer Res; 2012 Mar; 10(3):305-15. PubMed ID: 22246235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MicroRNA let-7a represses chemoresistance and tumourigenicity in head and neck cancer via stem-like properties ablation.
    Yu CC; Chen YW; Chiou GY; Tsai LL; Huang PI; Chang CY; Tseng LM; Chiou SH; Yen SH; Chou MY; Chu PY; Lo WL
    Oral Oncol; 2011 Mar; 47(3):202-10. PubMed ID: 21292542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mitochondrial oxidation by PDK2 inhibition reverses cisplatin resistance in head and neck cancer.
    Roh JL; Park JY; Kim EH; Jang HJ; Kwon M
    Cancer Lett; 2016 Feb; 371(1):20-9. PubMed ID: 26607904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crm1 knockdown by specific small interfering RNA reduces cell proliferation and induces apoptosis in head and neck cancer cell lines.
    Özdaş S; Özdaş T
    Turk J Biol; 2018; 42(2):132-143. PubMed ID: 30814875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropeptide Substance P Enhances Inflammation-Mediated Tumor Signaling Pathways and Migration and Proliferation of Head and Neck Cancers.
    Singh S; Kumaravel S; Dhole S; Roy S; Pavan V; Chakraborty S
    Indian J Surg Oncol; 2021 Apr; 12(Suppl 1):93-102. PubMed ID: 33994734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.